PharVision Advisers »

Cognyte Software shares owned by PharVision Advisers

Quarter-by-quarter ownership of Cognyte Software (CGNT) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Cognyte Software

Tip: Access up to 7 years of quarterly data

All positions including Cognyte Software held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognyte Software by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $208k 25k 8.40

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Cognyte Software

Edenbrook Capital
Luke P. La Valle, Jr.
Value Base
Neuberger Berman Group
Acadian Asset Management
Y.D. More Investments
Driehaus Capital Management
William Blair Investment Management
Westerly Capital Management
Connor, Clark & Lunn Investment Management
Ameriprise Financial
Scalar Gauge Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Citadel Advisors

View all funds holding Cognyte Software